Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 11:14 PM
Ignite Modification Date: 2025-12-25 @ 8:49 PM
NCT ID: NCT02446769
Description: None
Frequency Threshold: 0
Time Frame: 60 days
Study: NCT02446769
Study Brief: A Pilot Study to Assess the Effects of a Novel Application of Averaged Volume Assured Pressure Support Ventilation (AVAPS-AE) Therapy on Re-hospitalization in Patients With Sleep-Disordered Breathing With Co-morbid COPD
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Screening Period All participants that signed the consent. 0 None 0 18 0 18 View
Standard of Care Evaluation and treatment of the participant's sleep disordered breathing will be per their participant's health care provider's usual care pathway. 0 None 0 4 0 4 View
Experimental: AVAPS-AE Non-invasive Ventilation Therapy Participants will be initiated on AVAPS-AE therapy (intervention arm) for 60 days. AVAPS-AE is a mode of therapy (Philips Respironics Inc, Monroeville, Pa) with potential advantages over the currently established modes of non-invasive positive pressure ventilation (CPAP and bilevel therapy). This mode of therapy incorporates AVAPS (automated adjustable IPAP setting to maintain target ventilation with a settable rate of change), Auto EPAP and Auto Back up Rate. 0 None 1 3 0 3 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Hyperkalemia NON_SYSTEMATIC_ASSESSMENT Cardiac disorders None View
Cardiac Arrhythmia NON_SYSTEMATIC_ASSESSMENT Cardiac disorders None View
Acute Kidney Infection NON_SYSTEMATIC_ASSESSMENT Renal and urinary disorders None View
Fall secondary loss of consciousness NON_SYSTEMATIC_ASSESSMENT General disorders None View
Other Events(If Any):